5-HTT LPR	serotonin-transporter-linked promoter region
CATIE	Clinical Antipsychotic Trials of Intervention Effectiveness
COMT	catechol-o-methyl transferase
CYP	cytochrome-P450
DAT	dopamine transporter
DRD1	dopamine-1 receptors
DRD2	dopamine-2 receptors
DRD3	dopamine-3 receptors
DRD4	dopamine-4 receptors
EHF	ETS homologous factor, solute carrier family 26 member 9 (SLC26A9)
EPS	extrapyramidal symptoms
GWAS	genome-wide association studies
HLA	human leukocyte antigen
HTR2A	serotonin-2A receptors
HTR2C	serotonin-2A receptors
IGNITE	Implementing Genomics in Practice
IL1A	interleukin1-alpha
MC4R	melanocortin 4 receptor
MDR1	multiple drug resistance-1
NADPH	nicotinamide adenine dinucleotide phosphate
PD	pharmacodynamic
PG	pharmacogenetic
PGx	pharmacogenomic
PK	pharmacokinetic
SLC26A9	solute carrier family 26 member 9
SLC6A4	solute carrier family 6 member 4—serotonin transporter gene
SNP	single nucleotide polymorphism
TD	tardive dyskinesia